Fitzgerald Meghan 4
4 · Roivant Sciences Ltd. · Filed Sep 14, 2023
Insider Transaction Report
Form 4
Fitzgerald Meghan
Director
Transactions
- Award
Common Shares
2023-09-12+8,937→ 10,089 total - Award
Stock Option (Right to Buy)
2023-09-12+13,334→ 13,334 totalExercise: $11.22Exp: 2033-09-11→ Common Shares (13,334 underlying)
Footnotes (2)
- [F1]Reflects an annual award of restricted stock units with respect to Common Shares ("RSUs") granted pursuant to the Company's 2021 Equity Incentive Plan and the Company's Non-Employee Director Compensation Policy. The award of RSUs is scheduled to vest 100% on September 12, 2024, subject generally to the reporting person's continuous service through such date.
- [F2]Reflects an annual award of stock options to purchase Common Shares granted pursuant to the Company's 2021 Equity Incentive Plan and the Company's Non-Employee Director Compensation Policy. The award of stock options is scheduled to vest and become exercisable 100% on September 12, 2024, subject generally to the reporting person's continuous service through such date.